Kevin Rattigan

8PUBLICATIONS
33CO-AUTHORS
Molecular targetsCancer diagnosisHaematological tumoursCancer cell biologyNanotoxicology, health and safety
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Feb 24, 2026
A metabolism-specific drug-repurposing screen reveals itraconazole as a potent OXPHOS inhibitor in acute myeloid leukemia.

Ekaterini Himonas, Lucie de Beauchamp, Désirée Zerbst

|Jun 12, 2024
Nutrient-sensitizing drug repurposing screen identifies lomerizine as a mitochondrial metabolism inhibitor of chronic myeloid leukemia.

Ahmed Khalaf, Lucie de Beauchamp, Eric Kalkman

|Mar 02, 2024
Inhibition of mitochondrial folate metabolism drives differentiation through mTORC1 mediated purine sensing.

Martha M Zarou, Kevin M Rattigan, Daniele Sarnello

|Jul 25, 2023
Arginine dependency is a therapeutically exploitable vulnerability in chronic myeloid leukaemic stem cells.

Kevin M Rattigan, Martha M Zarou, Zuzana Brabcova

|Jan 12, 2023
Metabolism in stem cell-driven leukemia: parallels between hematopoiesis and immunity.

Kevin M Rattigan, Martha M Zarou, G Vignir Helgason

|Sep 29, 2021
ULK1 inhibition promotes oxidative stress-induced differentiation and sensitizes leukemic stem cells to targeted therapy.

Angela Ianniciello, Martha M Zarou, Kevin M Rattigan

Pageof 2

Frequent Collaborators

6 joint publications

Vignir Helgason

4 joint publications

Martha M Zarou

4 joint publications

David Sumpton

3 joint publications

Karen Dunn